Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The objective of this clinical trial was to understand whether supplementation of Moringa oleifera leaf powder improved glycemic management in Sahrawi women with type 2 diabetes living in refugee camps. The main question sought to be answered was:
- Does daily supplementation of Moringa oleifera leaf powder, in addition to oral hypoglycemic therapy, improve glycosylated hemoglobin and fasting blood glucose?
Researchers compared Moringa supplementation with no Moringa consumption to see if Moringa oleifera worked to improve glycemic control.
Participants had to:
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Moringa | Experimental | The experimental group received for 3 months a daily supplementation of 10g of Moringa oleifera leaf powder to consume within the two main meals. |
|
| Control | No Intervention | The control group were asked to refrain from consuming Moringa oleifera leaves throughout the study period (3 months). |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Supplementation of Moringa oleifera leaf powder | Dietary Supplement | Women in the experimental group were asked to consistently take the prescribed oral hypoglycemic therapy and to maintain their lifestyle and eating habits. In addition, for the duration of the study (3 months), the experimental group was provided with 10 g of Moringa oleifera leaf powder daily to be consumed with main meals. |
| Measure | Description | Time Frame |
|---|---|---|
| Glycosylated hemoglobin (HbA1c) | Glycosylated hemoglobin was measured at recruitment and at the end of the study (three months) | |
| Fasting glucose | Fasting glucose was measured at recruitment and at the end of the study (three months) |
| Measure | Description | Time Frame |
|---|---|---|
| BMI | BMI were measured at recruitment and at the end of the study (3 months) | |
| Waist circumference | Waist circumference were measured at recruitment and at the end of the study (3 months) | |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Dispensaris of Edchedería, Bir Lehlu, Mahbes, and Farsia (Smara camp) | Tindouf | Algeria |
Not provided
| ID | Term |
|---|---|
| D003924 | Diabetes Mellitus, Type 2 |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Hip circumference |
| Hip circumference were measured at recruitment and at the end of the study (3 months) |
| % body fat | % of body fat were measured at recruitment and at the end of the study (3 months) |
| Blood pressure | Systolic and diastolic blood pressure | Systolic and diastolic blood pressure were measured at recruitment and at the end of the study (3 months) |
| D004700 | Endocrine System Diseases |